S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Harvard Management Company/Q1 2022

Harvard Management Company

Period: Q1 2022 Β· Filed: 2022-05-13
View on SEC EDGAR β†—
AUM
$990M
Total portfolio value
Positions
44
Reported securities
Top Holding
META
27.6% $273.7M
QoQ Changes
+2 / -4
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-05-13) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
METAMETA PLATFORMS INC$273.7M27.63%$220.42$582.90+164.4%
27.6%
GOOGLALPHABET INC$242.2M24.45%$137.85$359.91+161.1%
24.4%
LNWOSCIENTIFIC GAMES CORP$157.4M15.88%$58.75$72.79+23.9%
15.9%
ABCLABCELLERA BIOLOGICS INC$40.0M4.04%$9.75$8.11-16.8%
4.0%
EQRXEQRX INC$21.7M2.19%β€”β€”
2.2%
PCTPURECYCLE TECHNOLOGIES INC$20.0M2.02%$8.00$7.61-4.9%
2.0%
RVMDREVOLUTION MEDICINES INC$17.1M1.73%$25.51$189.24+641.8%
1.7%
RLAYRELAY THERAPEUTICS INC$16.2M1.63%$29.93$18.65-37.7%
1.6%
TXG10X GENOMICS INC$14.2M1.43%$76.07$39.01-48.7%
1.4%
GRABGRAB HOLDINGS LIMITED$12.9M1.30%$3.50$3.90+11.4%
1.3%
RXRXRECURSION PHARMACEUTICALS IN$10.8M1.09%$7.16$3.80-46.9%
1.1%
MEKAMELI KASZEK PIONEER CORP$10.3M1.04%β€”β€”
1.0%
FULCFULCRUM THERAPEUTICS INC$9.7M0.98%$23.65$3.84-83.8%
1.0%
RKLBXXXXROCKET LAB USA INC$8.1M0.81%β€”β€”
0.8%
AFRMAFFIRM HLDGS INC$8.0M0.81%$46.28$84.58+82.8%
0.8%
MUMICRON TECHNOLOGY INC$8.0M0.81%$76.15$975.56+1181.1%
0.8%
PRAXPRAXIS PRECISION MEDICINES I$8.0M0.80%$153.15$318.52+108.0%
0.8%
TNYATENAYA THERAPEUTICS INC$7.9M0.80%$11.78$0.79-93.3%
0.8%
INTCINTEL CORP$7.5M0.75%$46.32$120.35+159.8%
0.8%
NVDANVIDIA CORPORATION$7.2M0.72%$27.20$194.83+616.3%
0.7%
ADIANALOG DEVICES INC$6.9M0.70%$153.74$377.16+145.3%
0.7%
LRCXXXXXLAM RESEARCH CORP$6.7M0.68%β€”β€”
0.7%
TSMTAIWAN SEMICONDUCTOR MFG LTD$6.7M0.68%$97.37$434.16+345.9%
0.7%
AMATAPPLIED MATLS INC$6.7M0.67%$127.03$603.04+374.7%
0.7%
AMDADVANCED MICRO DEVICES INC$6.0M0.60%$109.34$517.82+373.6%
0.6%
QRVOQORVO INC$5.8M0.59%$124.10$87.57-29.4%
0.6%
KNTEKINNATE BIOPHARMA INC$5.6M0.57%β€”β€”
0.6%
TNGXTANGO THERAPEUTICS INC$5.4M0.54%$7.58$29.46+288.6%
0.5%
CFLTCONFLUENT INC$5.3M0.54%β€”β€”
0.5%
NRIXNURIX THERAPEUTICS INC$4.4M0.45%$14.01$23.97+71.1%
0.5%

Quarter-on-Quarter Activity

Q1 2022 vs. Q4 2021

New Positions (2)

TickerIssuerNotional
PCTTWPURECYCLE TECHNOLOGIES INC$2.0M
VIGLVIGIL NEUROSCIENCE INC$2.0M

Exited Positions (4)

TickerIssuerNotional
RPRXROYALTY PHARMA PLC$138.1M
ASMLASML HOLDING N V$7.2M
DADADADA NEXUS LTD$0.5M
SRZNWSURROZEN INC$0.1M

Increased (4)

TickerIssuerNotionalShares Ξ”Since Filing
METAMETA PLATFORMS INC$148.6M+230.8%+164.4%
PCTPURECYCLE TECHNOLOGIES INC$9.8M+133.6%-4.9%
GRABGRAB HOLDINGS LIMITED$-1.4M+84.2%+11.4%
GOOGLALPHABET INC$65.5M+42.7%+161.1%

Trimmed

None this quarter

← Back to Hedge Funds